Z-Cube
Overview
Z-Cube is the research venture of the Zambon Group, established in 2003 to explore innovation and research in the life sciences sector globally. It specializes in supporting the growth and acceleration of innovative startups by identifying and developing modern solutions that improve patients' lives. Z-Cube has invested in several venture capital funds in the life sciences sector across the United States, Spain, Luxembourg, and Italy. In addition to its investment activities, Z-Cube launched the Open Accelerator program in 2016, focusing on accelerating life sciences startups. The program aims to transform groundbreaking projects and ideas from researchers into viable businesses by providing funding, mentorship, and expertise. Over the years, Z-Cube has supported numerous startups, contributing to the advancement of healthcare solutions. Through its comprehensive approach, Z-Cube continues to play a pivotal role in fostering innovation within the pharmaceutical and biotechnology industries, bridging the gap between scientific research and market-ready healthcare solutions.
Investment Focus
- Innovative solutions in the pharmaceutical and biotechnology sectors
Reach Z-Cube directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Z-Cube
What sectors does Z-Cube invest in?
Z-Cube invests in Biotechnology, Pharmaceutical and Medical Device, and is based in Lombardy, Italy. Z-Cube is listed as a venture capital in the ConnectSafely investor database.
What stage does Z-Cube invest at?
Z-Cube backs companies at Pre-Seed, Seed, Series A, Series B, Growth and Late Stage.
Which regions does Z-Cube invest in?
Z-Cube invests across United States, Italy, Spain and Luxembourg.
Last updated · Source: ConnectSafely investor database
